Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  Guo, Yiru ^a   Stein, Adam B ^a   Wu, Wen Jian ^a   Tan, Wei ^a   Zhu, Xiaoping ^a   Li, Qian Hong ^a   Dawn, Buddhadeb ^a   Motterlini, Roberto ^b   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

^b NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Carbon monoxide releasing molecules; Myocardial ischemia; Reperfusion injury; Transition metal carbonyls

Indexed keywords

CARBOXYHEMOGLOBIN; RUTHENIUM DERIVATIVE; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART RATE; HEART WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; BODY TEMPERATURE; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CARDIOTONIC AGENTS; DRUG ADMINISTRATION SCHEDULE; HEART RATE; MALE; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; ORGANOMETALLIC COMPOUNDS; PILOT PROJECTS;

EID: 1942437473     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00971.2003     Document Type: Article

References (24)

1. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, and Kupiec-Weglinski JW. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35: 815-823, 2002.
2. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
3. Brune B and Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32: 497-504, 1987.
4. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, and Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8, 2003.
5. Coburn RF, Blakemore WS, and Forster RE. Endogenous carbon monoxide production in man. J Clin Invest 42: 1172-1178, 1963.
6. Coburn RF, Williams WJ, and Kahn SB. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 45: 460-468, 1966.
7. Guo Y, Bao W, Wu WJ, Shinmura K, Tang XL, and Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol 95: 479-484, 2000.
8. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 275: H1375-H1387, 1998.
9. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, and Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798-803, 2001.
10. Morita T, Perrella MA, Lee ME, and Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92: 1475-1479, 1995.
11. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24, 2002.
12. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, and Winslow RM. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83: 568-577, 1998.
13. Otterbein L, Soares M, Yamashita K, and Bach F. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003.
14. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 4: 309-319, 2002.
15. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
16. Otterbein LE, Mantell LL, and Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L688-L694, 1999.
17. Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, Green CJ, and Motterlini R. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 125: 1437-1444, 1998.
18. Sarady JK, Otterbein SL, Liu F, Otterbein LE, and Choi AM. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 27: 739-745, 2002.
19. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, and Heusch G. p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55: 690-700, 2002.
20. Sjostrand T. Endogenous formation of carbon monoxide in man under normal and pathological conditions. Scand J Clin Lab Invest 1: 201-214, 1949.
21. Song R, Mahidhara RS, Liu F, Ning W, Otterbein LE, and Choi AM. Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol 27: 603-610, 2002.
22. Wang R, Wang Z, and Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121: 927-934 1997.
23. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, and Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173, 2001.
24. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248-1258, 2003.